These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38762781)

  • 1. The significance of Syndecan 1, a new marker for endothelial dysfunction, in cases of fetal growth retardation.
    Oğuz Y; Ağaoğlu RT; Ulusoy CO; Kurt D; Özgürlük İ; Soysal Ç; Yılmaz Vural Z; Yakut Yücel K
    Am J Reprod Immunol; 2024 May; 91(5):e13858. PubMed ID: 38762781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral-placental-uterine ratio as novel predictor of late fetal growth restriction: prospective cohort study.
    MacDonald TM; Hui L; Robinson AJ; Dane KM; Middleton AL; Tong S; Walker SP
    Ultrasound Obstet Gynecol; 2019 Sep; 54(3):367-375. PubMed ID: 30338593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal plasma syndecan-1: a biomarker for fetal growth restriction.
    Juusela A; Jung E; Gallo DM; Bosco M; Suksai M; Diaz-Primera R; Tarca AL; Than NG; Gotsch F; Romero R; Chaiworapongsa T
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2150074. PubMed ID: 36597808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Doppler ultrasound at time of diagnosis of late-onset fetal growth restriction in predicting adverse perinatal outcome: prospective cohort study.
    Rizzo G; Mappa I; Bitsadze V; Słodki M; Khizroeva J; Makatsariya A; D'Antonio F
    Ultrasound Obstet Gynecol; 2020 Jun; 55(6):793-798. PubMed ID: 31343783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal plasma soluble neuropilin-1 is downregulated in fetal growth restriction complicated by abnormal umbilical artery Doppler: a pilot study.
    Porter B; Maulik D; Babbar S; Schrufer-Poland T; Allsworth J; Ye SQ; Heruth DP; Lei T
    Ultrasound Obstet Gynecol; 2021 Nov; 58(5):716-721. PubMed ID: 33533520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placental growth factor and fetoplacental Doppler indices in combination predict preterm birth reliably in pregnancies complicated by fetal growth restriction.
    Hong J; Crawford K; Cavanagh E; da Silva Costa F; Kumar S
    Ultrasound Obstet Gynecol; 2024 May; 63(5):635-643. PubMed ID: 37820083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of placental neuropilin-1 in fetal growth restriction.
    Maulik D; De A; Ragolia L; Evans J; Grigoryev D; Lankachandra K; Mundy D; Muscat J; Gerkovich MM; Ye SQ
    Am J Obstet Gynecol; 2016 Feb; 214(2):279.e1-279.e9. PubMed ID: 26409917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians.
    Vayssière C; Sentilhes L; Ego A; Bernard C; Cambourieu D; Flamant C; Gascoin G; Gaudineau A; Grangé G; Houfflin-Debarge V; Langer B; Malan V; Marcorelles P; Nizard J; Perrotin F; Salomon L; Senat MV; Serry A; Tessier V; Truffert P; Tsatsaris V; Arnaud C; Carbonne B
    Eur J Obstet Gynecol Reprod Biol; 2015 Oct; 193():10-8. PubMed ID: 26207980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biophysical and biochemical markers at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.
    Valiño N; Giunta G; Gallo DM; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):194-202. PubMed ID: 26094952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infant outcome after active management of early-onset fetal growth restriction with absent or reversed umbilical artery blood flow.
    Morsing E; Brodszki J; Thuring A; Maršál K
    Ultrasound Obstet Gynecol; 2021 Jun; 57(6):931-941. PubMed ID: 32862450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of three-dimensional power Doppler combined with two-dimensional Doppler ultrasonography for evaluating fetal growth restriction.
    Fan H; Li L; Hao C
    J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2322610. PubMed ID: 38418205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten-year experience of protocol-based management of small-for-gestational-age fetuses: perinatal outcome in late-pregnancy cases diagnosed after 32 weeks.
    Meler E; Mazarico E; Eixarch E; Gonzalez A; Peguero A; Martinez J; Boada D; Vellvé K; Gomez-Roig MD; Gratacós E; Figueras F
    Ultrasound Obstet Gynecol; 2021 Jan; 57(1):62-69. PubMed ID: 33159370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinctive patterns of placental lesions in pre-eclampsia vs small-for-gestational age and their association with fetoplacental Doppler.
    Paules C; Youssef L; Rovira C; Crovetto F; Nadal A; Peguero A; Figueras F; Eixarch E; Crispi F; Miranda J; Gratacós E
    Ultrasound Obstet Gynecol; 2019 Nov; 54(5):609-616. PubMed ID: 31115105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ophthalmic artery Doppler and biomarkers of impaired placentation at 36 weeks' gestation in pregnancies with small fetuses.
    Arechvo A; Wright A; Nobile Recalde A; Liandro R; Charakida M; Nicolaides KH
    Ultrasound Obstet Gynecol; 2024 Mar; 63(3):358-364. PubMed ID: 37902727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of small for gestational age neonates: screening by maternal factors, fetal biometry, and biomarkers at 35-37 weeks' gestation.
    Ciobanu A; Rouvali A; Syngelaki A; Akolekar R; Nicolaides KH
    Am J Obstet Gynecol; 2019 May; 220(5):486.e1-486.e11. PubMed ID: 30707967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are maternal hemodynamic indices markers of fetal growth restriction in pregnancies with a small-for-gestational-age fetus?
    Perry H; Lehmann H; Mantovani E; Thilaganathan B; Khalil A
    Ultrasound Obstet Gynecol; 2020 Feb; 55(2):210-216. PubMed ID: 31381215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of Serum Amphiregulin Concentrations in Pregnant Women Diagnosed with Isolated Fetal Growth Restriction in the Third Trimester.
    Ramadan FİA; Kale İ; Kobal BB; Ozel A; Muhcu M
    Z Geburtshilfe Neonatol; 2024 Apr; 228(2):161-165. PubMed ID: 37625442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating syndecan-1 is reduced in pregnancies with poor fetal growth and its secretion regulated by matrix metalloproteinases and the mitochondria.
    Garcha D; Walker SP; MacDonald TM; Hyett J; Jellins J; Myers J; Illanes SE; Nien JK; Schepeler M; Keenan E; Whigham CA; Cannon P; Murray E; Nguyen TV; Kandel M; Masci J; Murphy C; Cruickshank T; Pritchard N; Hannan NJ; Brownfoot F; Roddy Mitchell A; Middleton A; Pell G; Wong GP; Tong S; Kaitu'u-Lino TJ
    Sci Rep; 2021 Aug; 11(1):16595. PubMed ID: 34400721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of cardiac sphericity index among intrauterine growth restriction and normal fetuses.
    Borna S; Khanjany S; Hantoushzade S; Khazardoost S; Mirzaeian S; Ariana S; Hashemnezhad M
    J Obstet Gynaecol; 2022 May; 42(4):614-619. PubMed ID: 34472415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Added value of cerebro-placental ratio and uterine artery Doppler at routine third trimester screening as a predictor of SGA and FGR in non-selected pregnancies.
    Rial-Crestelo M; Martinez-Portilla RJ; Cancemi A; Caradeux J; Fernandez L; Peguero A; Gratacos E; Figueras F
    J Matern Fetal Neonatal Med; 2019 Aug; 32(15):2554-2560. PubMed ID: 29447050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.